James Tyrrell specialises in combining corporate communications and policy consulting to support market access, government relations and product launches for companies and organisations. He is an expert in cardiovascular, immuno-oncology, virology and diagnostic product launches, policy development and market expansion. A senior director in APCO’s Singapore office, James leads APCO’s Global Health practice. Previously he spent five years in APCO’s London office where he led the European Health practice.
Prior to joining APCO, James was deputy managing director at Insight Consulting Group (ICG) which he co-founded in early 2006. With over two decades of experience in the industry, he has spearheaded a host of award-winning programmes and campaigns across a variety of sectors for some of the world’s largest companies.
James’ expert knowledge of market access and health technology appraisal has enabled him to work extensively on disease awareness and guideline development throughout his career at the national level and also within the World Health Organisation. He has provided corporate and brand consulting for most global pharmaceutical and biotech companies, including Allergan Aesthetics, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Gilead, GSK, LumiraDx, Menarini, Novartis, Pfizer and Sanofi, as well as supporting patient advocacy and professional organisations with communications advice in numerous therapeutic areas.
James regularly contributes to industry media and has served as vice-chairman of the Chartered Institute for Public Relations Public Affairs Group. He has been recognised for his achievements in the communications industry by being named as Consultant of the Year at the lobbying industry’s Public Affairs News Awards.
James is a graduate of the University of Southampton and holds a bachelor’s degree in politics.
